Siirry ensisijaiseen navigaatioon, Skip to primary navigation, Hoppa till primärnavigering Siirry hakuun, Skip to search, Hoppa till sök Siirry päänavigaatioon, Skip to main navigation, Hoppa till huvudnavigering Siirry sisältöalueeseen, Skip to main content, Hoppa till huvudinnehåll Siirry alatunnistenavigaatioon, Skip to footer navigation, Hoppa till sidfältnavigering
  1. Suomeksi
  2. På svenska
  3. In English
Finnish Competition and Consumer Authority
  • Facts & Advice
     

    Marketing and advertising

    • Good marketing practices
    • Indicating prices
    • Sales and offers
    • Corrections of mistakes in advertising
    • Recognisability of advertising
    • Direct marketing may be refused
    • Claims and comparisons
    • More topics

    Defects, delays and reclamations

    • Defective goods
    • Defective services
    • Delays in delivery
    • Defective cars
    • Defects in housing transactions
    • Residential care housing
    • Telephone and internet connections
    • More topics

    Buying and selling

    • Guarantee
    • Customer services
    • Presents and gift vouchers
    • Contracts
    • Cancelling a purchase
    • Scams
    • Gym memberships
    • More topics

    Travel and instructions for agencies

    • Travel and transport
    • Air passengers´ rights
    • How to register a travel company
    • Instructions for registered travel companies
    • Register of package travel agencies
    • If a travel agency goes bankrupt
    • More topics

    Payment, bills and collection

    • Financial management
    • Receipt
    • Credit
    • Payment arrangements
    • Loss of a payment card
    • Delayed payment and collection
    • More topics

    Competition affairs

    • Competition restraints
    • Merger control
    • Competition neutrality
    • Do you suspect a competition restraint? Tip us off!
    • Be the first one to leave a cartel
    • More topics
    • Marketing and advertising
    • Buying, selling and making contracts
    • Payment, bills, debt collection
    • Defects and delays
    • Travelling and travel agencies
    • Competition Affairs
  • Decisions & publications
     

    Competition affairs

    Documents are only in Finnish.

    • FCCA's decisions in competition affairs
    • More topics

    Motions and statements

    Documents are only in Finnish.

    • FCCA's motions and statements
    • More topics

    Consumer affairs

    Documents are only in Finnish.

    • Consumer ombudsmans' decisions
    • More topics

    Guidelines for consumer protection

    • Guidelines for consumer protection
    • More topics

    Search

    Documents are only in Finnish.

    • Advanced search
    • More topics

    Publications

    • Guidelines on the application of the Competition Act
    • Joint Nordic Reports
    • More topics
    • Competition Affairs
    • Consumer affairs
    • Motions and statements
    • Publications
  • Current issues
    • Press releases
    • News
    • Newsletters
  • FCCA
    • Online consumer services
    • The Consumer Ombudsman
    • European Consumer Centre in Finland
    • Organisation
    • Responsibilities
    • Statistics
    • Planning and monitoring of operations
    • Contact information
    • Online services and privacy protection
  • Consumer Advice
    • File a complaint with the company
    • Duties of consumer advisors
  • Contact
    • Competition affairs
    • Consumer affairs
    • Administration
    • ICT and digitalisation
    • Management
    • Advocacy and research
    • Communications
    • Data protection
  • Frontpage
  • Current issues
  • Press releases
  • 2020
https://www.kkv.fi/en/current-issues/press-releases/2020/10.11.2020-consumer-ombudsman-demands-that-naturamed-pharma-pay-the-eur-100000-conditional-fine-levied-against-it/
  • Frontpage
  • Current issues
  • Press releases
  • 2020

Current issues

  • Press releases
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
  • News
  • Newsletters

Misleading marketing is an ongoing problem in the natural products industry – the Consumer Ombudsman demands that NaturaMed Pharma pay the EUR 100,000 conditional fine levied against it

Listen
Facebook Twitter LinkedIn
10 November 2020

NaturaMed Pharma has been marketing dietary supplements under the pretext that these are free gifts and and product samples, even though this offer is actually a paid subscription. These types of subscription traps are common in the marketing of natural products. The Consumer Ombudsman demands that NaturaMed Pharma pay the fine levied against it and also seeks a ban issued by the Market Court against the company.

In the years 2019 and 2020, NaturaMed Pharma distributed unaddressed letter inserts in periodical publications, inviting the reader to accept a watch and dietary supplement package at no charge. The fact that neither the gift nor the products may be ordered without agreeing to a subscription is not stated until the end of a multi-page advertising letter, on a response card. Information on the subscription is printed in a font size that is considerably smaller than that used for the other text in the letter. This type of misleading approach is known as a subscription trap.

The Consumer Ombudsman issued a ban to NaturaMed Pharma in 2010 for misleading marketing. Because the company continues to employ misleading marketing practices, the Consumer Ombudsman has now requested that Market Court issue the company with a ban along with a conditional fine of EUR 100,000.

NaturaMed Pharma is not the only natural products company that employs this type of marketing — indeed, misleading marketing practices seem to be an ongoing problem in the natural products industry.

“A sample or introductory package that is claimed to be free of charge often leads to a subscription. The behavioural biases of consumers are taken advantage of in doing this. The consumer’s attention is snared on a benefit that is misleadingly emphasised in marketing, and the purchasing decision is made based on this,” explains Consumer Ombudsman Katri Väänänen.

The Consumer Ombudsman emphasises that the contents and total price of the order as well as information on the right to cancel must be stated in all distance selling.

Repeated violations indicate disregard

Because NaturaMed Pharma has repeatedly violated the ban issued to it in its letter marketing, the Consumer Ombudsman has also requested that the Market Court issue the company a new ban. It has been proposed that the ban currently being sought be further enhanced with a EUR 150,000 conditional fine.

“Repeated misleading marketing practices demonstrate a clear disregard for the principles of consumer protection and the ban issued to the company,” says Väänänen.

By law, no expressions suggesting gratuitousness, such as ‘free’ or ‘0 euros’, may be used in marketing in cases involving a paid subscription. The Consumer Ombudsman also requests that the Market Court ban NaturaMed Pharma from using these types of expressions in connection with subscriptions.

Industry problems also extend to telephone marketing

Although the ban currently being sought concerns the letter marketing being conducted by NaturaMed Pharma, misleading letter marketing is not the only problem in the industry. Natural products and dietary supplements are sold using misleading practices by telephone and, according to contacts received by the Finnish Competition and Consumer Authority, the elderly have been particularly targeted.

“Telephone sales causes so many problems for consumers that its regulation should be tightened once and for all,” stresses Väänänen.

Further information on the subject:

  • Misleading telephone sales of dietary supplements and natural products is a nuisance for the elderly direct procurements, FCCA press release 9 April 2020
  • Several reports on telemarketing by Health Group Finland, Super Living Products and Vitaelife Pharma, FCCA press release 17 June 2020

Keywords: Marketing, Markkinaoikeus
Updated 10.11.2020 Print
Facebook Twitter LinkedIn
Updated 10.11.2020 Print
Facebook Twitter LinkedIn
  • © FCCA
  • Contacts
  • Feedback
  • Data protection
  • About cookies
  • Accessibility
  • © FCCA